Option Care Health, Inc. (NASDAQ:OPCH) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have earned an average recommendation of “Moderate Buy” from the eight brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $35.50.

A number of brokerages recently commented on OPCH. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and raised their target price for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. JMP Securities reiterated a “market outperform” rating and issued a $36.00 price objective on shares of Option Care Health in a research note on Tuesday, April 22nd. Barrington Research reiterated an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Wednesday, April 30th. UBS Group upgraded Option Care Health from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $38.00 to $40.00 in a research note on Wednesday, April 30th. Finally, JPMorgan Chase & Co. lifted their price objective on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th.

Option Care Health Stock Performance

Shares of Option Care Health stock opened at $32.03 on Friday. The business has a 50-day moving average of $33.05 and a 200 day moving average of $29.24. Option Care Health has a 12 month low of $21.39 and a 12 month high of $35.53. The stock has a market capitalization of $5.24 billion, a price-to-earnings ratio of 26.92, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.26 billion. During the same period last year, the business posted $0.26 EPS. Option Care Health’s revenue for the quarter was up 16.3% on a year-over-year basis. As a group, sell-side analysts forecast that Option Care Health will post 1.22 earnings per share for the current year.

Insiders Place Their Bets

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company’s stock, valued at approximately $1,495,835.24. This trade represents a 40.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.64% of the stock is owned by corporate insiders.

Institutional Trading of Option Care Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OPCH. Wellington Management Group LLP raised its holdings in Option Care Health by 84.6% during the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company’s stock worth $425,143,000 after purchasing an additional 8,400,208 shares in the last quarter. Durable Capital Partners LP acquired a new position in shares of Option Care Health in the 1st quarter valued at $122,905,000. Norges Bank acquired a new position in shares of Option Care Health in the 4th quarter valued at $60,219,000. Nuveen LLC acquired a new position in shares of Option Care Health in the 1st quarter valued at $70,965,000. Finally, Allspring Global Investments Holdings LLC increased its holdings in shares of Option Care Health by 6,525,926.1% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 1,500,986 shares of the company’s stock valued at $52,459,000 after acquiring an additional 1,500,963 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.